← Back to headlines
Protara Therapeutics Stock Gains as JP Morgan Initiates Overweight Rating
Protara Therapeutics saw its stock rise after JP Morgan initiated coverage of the company with an 'overweight' rating.
4 Mar, 15:07 — 4 Mar, 15:07
Sources
Showing 1 of 1 sources
Related Stories
New York Fed Chief Links Rising Bond Yields to Strong U.S. Economic Outlook
1h ago
Analysts Warn Sustained High Bond Yields Could Dampen Stock Rally
1h ago
UK Fines Citibank London £4.7 Million Over Russia Sanctions Breaches
4h ago
Markets Price In High Likelihood of September Rate Hikes by Fed and BOJ
5h ago